Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus sufentanil for induction during total intravenous anesthesia in adults
ChiCTR2100047296Phase 4Recruiting
- Sponsor
- Zichang People's Hospital
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and sufentanil in None (2 arms), sponsored by Zichang People's Hospital. Primary endpoints: Heart rate, Systolic blood pressure and 2 more. Started Jun 2021; status: recruiting.
02
Drugs
nalbuphinesufentanil
Beyond the preview
Go deeper on ChiCTR2100047296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047296.